Versartis, Inc. (VSAR)

[Marilynt]

Versartis, Inc. (VSAR) Given “Buy” Rating at Cantor Fitzgerald
September 23rd, 2017 - Filed Under - by Stacy Sanders

Cantor Fitzgerald reaffirmed their buy rating on shares of Versartis, Inc. (NASDAQ:VSAR) in a report issued on Friday. They currently have a $14.00 price target on the biopharmaceutical company’s stock, down from their previous price target of $34.00.

https://www.dailypolitical.com/2017/09/23/versartis-inc-vsar-given-buy-rating-at-cantor-fitzgerald.html